Breast augmentation has evolved significantly, introducing advancements that yield more natural outcomes, reduced complications, and shorter recovery times. One of the most notable innovations is the scarless, painless breast augmentation technique utilizing Motiva implants. This state-of-the-art method employs a trans-axillary sub-glandular approach, offering patients an almost invisible and seamless solution for enhancing their breasts.

The procedure involves inserting Motiva breast implants through a small incision in the underarm (trans-axillary approach), which leaves no visible scars on the breasts. Although the trans-axillary method has been used for some time, applying it in the sub-glandular plane with Motiva’s advanced implant technology represents a significant advancement. This technique draws inspiration from Europe’s Mia Femtech technology, which employs an injectable, diamond-shaped implant. While Mia Femtech is not yet FDA-approved, its principles can be successfully incorporated into breast augmentation practices in the U.S.

Traditional breast augmentation typically involves placing implants beneath the muscle (submuscular). While this approach has proven effective, it presents several drawbacks, such as muscle distortion during movement (commonly referred to as animation deformity) and issues with breast crease adjustment, which may cause the implants to sit too low, leading to “bottoming out.”

The sub-glandular placement addresses these concerns by allowing the implant to rest more naturally within the breast tissue without affecting the breast fold. However, this technique has traditionally been associated with a higher risk of capsular contracture (the formation of scar tissue), especially when using smooth round implants. This is where Motiva implants come into play, offering a groundbreaking solution to these challenges.

Motiva implants are designed with cutting-edge technology that addresses the limitations of traditional implants:

Viscoelastic ProgressiveGel®: This 6th-generation, highly cohesive silicone gel mimics the look and feel of natural breast tissue. It offers a soft, pliable consistency while maintaining shape and structure.

TrueMonobloc® Shell: This next-generation gel-bonding technology unifies the implant’s shell, patch, and gel into a single unit. It enhances durability and allows for smooth insertion through small incisions without risking gel fracture.

Motiva SmoothSilk® Surface: The implant’s 4-micron surface is designed for enhanced biocompatibility, reducing inflammation, bacterial attachment, and ultimately, the risk of capsular contracture.

BluSeal® Technology: A visual indicator of the implant's barrier layer that ensures quality and integrity, offering peace of mind for both patient and surgeon.